Hemant Surgical Industries Ltd
₹ 136
5.00%
22 Nov
- close price
About
Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]
Key Points
- Market Cap ₹ 143 Cr.
- Current Price ₹ 136
- High / Low ₹ 225 / 115
- Stock P/E 15.7
- Book Value ₹ 55.6
- Dividend Yield 0.00 %
- ROCE 29.8 %
- ROE 25.0 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 54.0% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.9%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Earnings include an other income of Rs.4.08 Cr.
- Working capital days have increased from 30.6 days to 74.4 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 51 | 56 | 56 | 60 | 101 | 109 | 106 | 107 | |
| 48 | 53 | 53 | 57 | 95 | 98 | 95 | 96 | |
| Operating Profit | 2 | 3 | 3 | 3 | 6 | 11 | 10 | 11 |
| OPM % | 5% | 5% | 5% | 5% | 6% | 10% | 10% | 10% |
| 0 | 0 | 0 | 1 | 2 | 2 | 4 | 4 | |
| Interest | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 |
| Depreciation | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 1 | 1 | 1 | 1 | 6 | 10 | 13 | 13 |
| Tax % | 10% | 8% | 41% | 9% | 25% | 24% | 23% | |
| 1 | 1 | 0 | 1 | 5 | 8 | 10 | 9 | |
| EPS in Rs | 50.76 | 61.02 | 27.00 | 73.43 | 248.92 | 412.53 | 9.39 | 8.68 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 21% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 54% |
| 3 Years: | 93% |
| TTM: | -2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 32% |
| Last Year: | 25% |
Balance Sheet
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 8 | 10 | 10 |
| Reserves | 5 | 6 | 5 | 8 | 11 | 16 | 44 | 48 |
| 9 | 11 | 14 | 14 | 10 | 7 | 7 | 14 | |
| 12 | 14 | 23 | 15 | 32 | 34 | 35 | 43 | |
| Total Liabilities | 28 | 33 | 44 | 40 | 54 | 65 | 97 | 116 |
| 7 | 8 | 10 | 11 | 12 | 13 | 18 | 33 | |
| CWIP | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
| Investments | -0 | -0 | 1 | 0 | 1 | 0 | 5 | 0 |
| 21 | 25 | 33 | 29 | 42 | 51 | 74 | 83 | |
| Total Assets | 28 | 33 | 44 | 40 | 54 | 65 | 97 | 116 |
Cash Flows
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| -0 | -0 | 2 | -4 | 12 | 6 | -8 | |
| -0 | -0 | -2 | -2 | -0 | -3 | -9 | |
| -0 | -0 | 2 | 5 | -8 | -1 | 21 | |
| Net Cash Flow | -0 | -0 | 2 | -2 | 4 | 3 | 5 |
Ratios
Figures in Rs. Crores
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 35 | 36 | 35 | 26 | 56 | 58 | 75 |
| Inventory Days | 64 | 73 | 125 | 113 | 57 | 67 | 99 |
| Days Payable | 102 | 97 | 143 | 89 | 92 | 110 | 116 |
| Cash Conversion Cycle | -3 | 12 | 17 | 51 | 21 | 15 | 58 |
| Working Capital Days | 12 | 23 | 14 | 66 | 2 | 16 | 74 |
| ROCE % | 15% | 12% | 14% | 32% | 45% | 30% |
Documents
Announcements
-
Statement Of Deviation For The Period Ended On September 30, 2024
13 Nov - Statement of deviation in IPO fund utilization.
- Un-Audited Financial Results Of The Company For The Half Year Ended On September 30, 2024. 13 Nov
-
Board Meeting Outcome for The Meeting Held On Wednesday, November 13, 2024
13 Nov - Board approved unaudited financial results for H1 2024.
-
Board Meeting Intimation for Meeting Of The Board Of The Company Will Be Held On Wednesday, November 13, 2024.
5 Nov - Board meeting to approve un-audited financial results.
-
Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015
10 Oct - Additional details on fire incident and damage assessment.
Business Overview:[1][2]
HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including
a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc.
b) Design and manufacture of a range of nebulisers, which are
marketed under the company’s AERO brand
c) HSIL also refurbishes second-hand dialysis machines, manufactures
and supplies related accessories, dialysers and haemodialysis solutions